|
2017 Journal Article The Use of Plasmapheresis in Patients with Bronchiectasis with Pseudomonas aeruginosa Infection and Inhibitory AntibodiesWells, Timothy J., Davison, John, Sheehan, Emma, Kanagasundaram, Suren, Spickett, Gavin, MacLennan, Calman A., Stockley, Robert A., Cunningham, Adam F., Henderson, Ian R. and De Soyza, Anthony (2017). The Use of Plasmapheresis in Patients with Bronchiectasis with Pseudomonas aeruginosa Infection and Inhibitory Antibodies. American Journal of Respiratory and Critical Care Medicine, 195 (7), 955-958. doi: 10.1164/rccm.201603-0599LE |
|
2026 Journal Article Treatment of <i>Pseudomonas</i> by removal of cloaking antibodies; is common polysaccharide antigen a factor?Monteith, Joshua N, Ledger, Emma L, Chamoun, Michelle N, Henderson, Ian R, Goldberg, Joanna B, Smith, Daniel, Chambers, Daniel C, Apte, Simon H and Wells, Timothy J (2026). Treatment of Pseudomonas by removal of cloaking antibodies; is common polysaccharide antigen a factor?. The Journal of Infectious Diseases, 233 (4) jiag002, e948-e956. doi: 10.1093/infdis/jiag002 |
|
2025 Conference Publication Cloaking antibodies prevent immune detection and destruction of inflammatory Crohn’s microbiota, resulting in treatment resistance: the first description of a central pathogenic mechanismFeng, Wenkang, Tovey-Matthews, Abigail, Schulberg, Julien D., Hamilton, Amy L., Lovett, Grace C., Wright, Emily K., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2025). Cloaking antibodies prevent immune detection and destruction of inflammatory Crohn’s microbiota, resulting in treatment resistance: the first description of a central pathogenic mechanism. Digestive Disease Week (DDW) 2025, San Diego, CA United States, 3-6 August 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(25)02172-9 |
|
2025 Journal Article Ceftriaxone-loaded liposomal nanoparticles for pulmonary delivery against lower respiratory tract infections: development and characterizationPanthi, Vijay Kumar, Fairfull-Smith, Kathryn E., Wells, Timothy J., Wang, Tony and Islam, Nazrul (2025). Ceftriaxone-loaded liposomal nanoparticles for pulmonary delivery against lower respiratory tract infections: development and characterization. Pharmaceuticals, 18 (3) 414. doi: 10.3390/ph18030414 |
|
2025 Journal Article Emerging antimicrobial therapies for Gram-negative infections in human clinical useHickson, Sarah M., Ledger, Emma L. and Wells, Timothy J. (2025). Emerging antimicrobial therapies for Gram-negative infections in human clinical use. npj Antimicrobials and Resistance, 3 (1) 16, 1-15. doi: 10.1038/s44259-025-00087-2 |
|
2025 Journal Article Inhaled combined antibacterials against biofilm-forming antibiotic-resistant bacteria for the management of pulmonary bacterial infectionsSuraweera, Ruwani K., Spann, Kirsten M., Wells, Timothy J. and Islam, Nazrul (2025). Inhaled combined antibacterials against biofilm-forming antibiotic-resistant bacteria for the management of pulmonary bacterial infections. Journal of Drug Delivery Science and Technology, 104 106555, 106555. doi: 10.1016/j.jddst.2024.106555 |
|
2025 Journal Article Understanding the pathophysiology of Pseudomonas aeruginosa colonization as a guide for future treatment for chronic leg ulcersMatheus, Gabriela Gonzalez, Chamoun, Michelle N., Khosrotehrani, Kiarash, Sivakumaran, Yogeesan and Wells, Timothy J. (2025). Understanding the pathophysiology of Pseudomonas aeruginosa colonization as a guide for future treatment for chronic leg ulcers. Burns and Trauma, 13 tkae083, tkae083. doi: 10.1093/burnst/tkae083 |
|
2024 Journal Article Development and characterization of spray-dried combined levofloxacin–ambroxol dry powder inhaler formulationSuraweera, Ruwani K., Spann, Kirsten M., Izake, Emad L., Wells, Timothy J., Wang, Xiaodong and Islam, Nazrul (2024). Development and characterization of spray-dried combined levofloxacin–ambroxol dry powder inhaler formulation. Pharmaceutics, 16 (12) 1506, 1506. doi: 10.3390/pharmaceutics16121506 |
|
2024 Journal Article Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammationMcCulloch, Timothy R., Rossi, Gustavo R., Alim, Louisa, Lam, Pui Yeng, Wong, Joshua K. M., Coleborn, Elaina, Kumari, Snehlata, Keane, Colm, Kueh, Andrew J., Herold, Marco J., Wilhelm, Christoph, Knolle, Percy A., Kane, Lawrence, Wells, Timothy J. and Souza-Fonseca-Guimaraes, Fernando (2024). Dichotomous outcomes of TNFR1 and TNFR2 signaling in NK cell-mediated immune responses during inflammation. Nature Communications, 15 (1) 9871, 1-16. doi: 10.1038/s41467-024-54232-y |
|
2024 Journal Article Type 5 secretion system antigens as vaccines against Gram-negative bacterial infectionsDa Costa, Rochelle M., Rooke, Jessica L., Wells, Timothy J., Cunningham, Adam F. and Henderson, Ian R. (2024). Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections. npj Vaccines, 9 (1) 159, 159. doi: 10.1038/s41541-024-00953-6 |
|
2024 Journal Article Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killingPham, Amy, Tan, Kellynn K. Y., Ledger, Emma L., Smith, Daniel J., Reid, David W., Burr, Lucy, Chambers, Daniel C. and Wells, Timothy J. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology, 14 1426773, 1426773. doi: 10.3389/fcimb.2024.1426773 |
|
2024 Journal Article Mechanisms of antibody-dependent enhancement of infectious diseaseWells, Timothy J., Esposito, Tyron, Henderson, Ian R. and Labzin, Larisa I. (2024). Mechanisms of antibody-dependent enhancement of infectious disease. Nature Reviews Immunology, 25 (1) e33073, 6-21. doi: 10.1038/s41577-024-01067-9 |
|
2024 Conference Publication Does a leopard change its spots? Pseudomonas aeruginosa in cystic fibrosis after CFTR modulationLedger, Emma, Smith, Daniel, Teh, Jing Jie, Wood, Michelle, Whibley, Page, Morrison, Mark, Goldberg, Joanna, Reid, David and Wells, Timothy (2024). Does a leopard change its spots? Pseudomonas aeruginosa in cystic fibrosis after CFTR modulation. Abstracts of the 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Journal Article The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapyMcCulloch, Timothy R., Rossi, Gustavo R., Miranda‐Hernandez, Socorro, Valencia‐Hernandez, Ana Maria, Alim, Louisa, Belle, Clemence J., Krause, Andrew, Zacchi, Lucia F., Lam, Pui Yeng, Nakamura, Kyohei, Kupz, Andreas, Wells, Timothy J. and Souza‐Fonseca‐Guimaraes, Fernando (2024). The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy. Immunology and Cell Biology, 102 (8), 721-733. doi: 10.1111/imcb.12794 |
|
2024 Journal Article Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosisLedger, Emma L., Smith, Daniel J., Teh, Jing Jie, Wood, Michelle E., Whibley, Page E., Morrison, Mark, Goldberg, Joanna B., Reid, David W. and Wells, Timothy J. (2024). Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosis. The Journal of Infectious Diseases, 230 (3), e536-e547. doi: 10.1093/infdis/jiae051 |
|
2024 Journal Article Antibody-mediated serum resistance protects Pseudomonas aeruginosa during bloodstream infectionsHickson, Sarah M., Hoehensteiger, Johannes K., Mayer-Coverdale, Johanna, Torres, Von Vergel L., Feng, Wenkang, Monteith, Joshua N., Henderson, Ian R., McCarthy, Kate L. and Wells, Timothy J. (2024). Antibody-mediated serum resistance protects Pseudomonas aeruginosa during bloodstream infections. The Journal of Infectious Diseases, 230 (2), e221-e229. doi: 10.1093/infdis/jiad457 |
|
2023 Journal Article Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina cladesPham, Amy, Volmer, James G., Chambers, Daniel C., Smith, Daniel J., Reid, David W., Burr, Lucy and Wells, Timothy J. (2023). Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina clades. Frontiers in Microbiology, 14 1274280, 1-14. doi: 10.3389/fmicb.2023.1274280 |
|
2023 Conference Publication Goblet cell specific anti-apoptotic role of interleukin-24 in spondyloarthritis-associated ileitisCameron, Amy, Giri, Rabina, Begun, Jakob, Wells, Timothy, Thomas, Ranjeny and Bergot, Anne-Sophie (2023). Goblet cell specific anti-apoptotic role of interleukin-24 in spondyloarthritis-associated ileitis. ACR Convergence 2023, San Diego, CA, United States, 10 - 15 November 2023. Hoboken, NJ, United States: John Wiley & Sons. |
|
2023 Journal Article Leveraging the COVID-19 pandemic as a natural experiment to assess changes in antibiotic use and antibiotic-resistant E. coli carriage in semi-rural EcuadorAmato, Heather K., Loayza, Fernanda, Salinas, Liseth, Paredes, Diana, Garcia, Daniela, Sarzosa, Soledad, Saraiva-Garcia, Carlos, Johnson, Timothy J., Pickering, Amy J., Riley, Lee W., Trueba, Gabriel and Graham, Jay P. (2023). Leveraging the COVID-19 pandemic as a natural experiment to assess changes in antibiotic use and antibiotic-resistant E. coli carriage in semi-rural Ecuador. Scientific Reports, 13 (1) 14854. doi: 10.1038/s41598-023-39532-5 |
|
2023 Conference Publication Goblet cell specific anti-apoptotic role of interleukin-24 in spondyloarthritis-associated ileitisCameron, A., Giri, R., Begun, J., Wells, T., Bergot, A. S. and Thomas, R. (2023). Goblet cell specific anti-apoptotic role of interleukin-24 in spondyloarthritis-associated ileitis. EULAR 2023 European Congress of Rheumatology, Milan, Italy, 31 May-3 June 2023. London, United Kingdom: BMJ Group. doi: 10.1136/annrheumdis-2023-eular.1346 |
